Pacific Biosciences Of California Debt to Equity Ratio 2009-2019 | PACB

Current and historical debt to equity ratio values for Pacific Biosciences Of California (PACB) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Pacific Biosciences Of California debt/equity for the three months ending June 30, 2019 was 0.58.
Pacific Biosciences Of California Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-06-30 $0.04B $0.08B 0.58
2019-03-31 $0.05B $0.10B 0.47
2018-12-31 $0.02B $0.11B 0.13
2018-09-30 $0.01B $0.13B 0.11
2018-06-30 $0.01B $0.09B 0.17
2018-03-31 $0.01B $0.10B 0.14
2017-12-31 $0.01B $0.09B 0.16
2017-09-30 $0.01B $0.10B 0.10
2017-06-30 $0.01B $0.12B 0.09
2017-03-31 $0.01B $0.07B 0.19
2016-12-31 $0.02B $0.09B 0.19
2016-09-30 $0.02B $0.10B 0.16
2016-06-30 $0.02B $0.11B 0.14
2016-03-31 $0.02B $0.09B 0.17
2015-12-31 $0.02B $0.07B 0.20
2015-09-30 $0.02B $0.04B 0.36
2015-06-30 $0.02B $0.03B 0.43
2015-03-31 $0.01B $0.04B 0.35
2014-12-31 $0.01B $0.06B 0.26
2014-09-30 $0.01B $0.05B 0.26
2014-06-30 $0.01B $0.06B 0.23
2014-03-31 $0.01B $0.08B 0.18
2013-12-31 $0.01B $0.07B 0.19
2013-09-30 $0.01B $0.08B 0.16
2013-06-30 $0.01B $0.10B 0.13
2013-03-31 $0.02B $0.11B 0.14
2012-12-31 $0.00B $0.11B 0.00
2012-09-30 $0.00B $0.13B 0.02
2012-06-30 $0.00B $0.15B 0.02
2012-03-31 $0.00B $0.17B 0.02
2011-12-31 $0.00B $0.19B 0.02
2011-09-30 $0.00B $0.21B 0.02
2011-06-30 $0.00B $0.23B 0.02
2011-03-31 $0.00B $0.25B 0.01
2010-12-31 $0.00B $0.28B 0.01
2010-09-30 $0.00B $-0.27B -0.01
2010-06-30 $0.00B 0.00
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
2008-12-31 $0.00B $-0.10B -0.01
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.878B $0.079B
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $110.607B 23.57
Intuitive Surgical (ISRG) United States $57.377B 50.18
Edwards Lifesciences (EW) United States $46.171B 44.94
IDEXX Laboratories (IDXX) United States $24.227B 60.78
Fresenius Medical Care AG KGaA (FMS) Germany $20.503B 13.58
Teleflex (TFX) United States $17.007B 36.10
Olympus (OCPNY) Japan $16.422B 122.87
DexCom (DXCM) United States $15.345B 227.40
SONOVA HOLDING (SONVY) Switzerland $14.907B 0.00
Hologic (HOLX) United States $13.352B 21.08
Sysmex ADR (SSMXY) Japan $12.966B 34.96
STERIS (STE) Ireland $12.795B 29.51
Varian Medical Systems (VAR) United States $9.840B 23.54
ABIOMED (ABMD) United States $8.741B 50.03
Masimo (MASI) United States $8.124B 49.29
SARTORIUS AG (SARTF) Germany $6.158B 54.71
Integra LifeSciences Holdings (IART) United States $5.239B 23.38
Penumbra (PEN) United States $5.024B 180.50
Globus Medical (GMED) United States $4.990B 31.67
Elekta AB (EKTAY) Sweden $4.803B 38.32
LivaNova (LIVN) United Kingdom $3.912B 29.83
Cantel Medical (CMD) United States $3.689B 37.43
Tandem Diabetes Care (TNDM) United States $3.596B 0.00
Wright Medical Group (WMGI) Netherlands $2.735B 239.89
Nevro (NVRO) United States $2.563B 0.00
Nihon Kohden (NHNKY) Japan $2.551B 25.67
Integer Holdings (ITGR) United States $2.518B 17.81
Glaukos (GKOS) United States $2.293B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.701B 31.56
Silk Road Medical (SILK) United States $1.253B 0.00
Veracyte (VCYT) United States $1.251B 0.00
OPKO Health (OPK) United States $1.231B 0.00
Natus Medical (NTUS) United States $1.034B 24.09
ORTHOFIX MEDICAL INC (OFIX) United States $0.996B 31.27
Accelerate Diagnostics (AXDX) United States $0.981B 0.00
CryoLife (CRY) United States $0.981B 93.43
Tactile Systems Technology (TCMD) United States $0.954B 117.91
Inogen (INGN) United States $0.917B 22.48
Luminex (LMNX) United States $0.916B 0.00
Corindus Vascular Robotics (CVRS) United States $0.891B 0.00
Mesa Laboratories (MLAB) United States $0.856B 39.54
AngioDynamics (ANGO) United States $0.704B 23.02
Quotient (QTNT) Switzerland $0.674B 0.00
AxoGen (AXGN) United States $0.640B 0.00
Intersect ENT (XENT) United States $0.500B 0.00
Si-Bone (SIBN) United States $0.485B 0.00
OrthoPediatrics (KIDS) United States $0.480B 0.00
Fluidigm (FLDM) United States $0.419B 0.00
ViewRay (VRAY) United States $0.414B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.376B 14.43
Alphatec Holdings (ATEC) United States $0.367B 0.00
GenMark Diagnostics (GNMK) United States $0.366B 0.00
Sientra (SIEN) United States $0.336B 0.00
Semler Scientific (SMLR) United States $0.299B 50.55
Accuray (ARAY) United States $0.247B 0.00
RTI Surgical (RTIX) United States $0.238B 35.78
IRadimed (IRMD) United States $0.235B 38.92
CRH Medical (CRHM) Canada $0.231B 80.25
SeaSpine Holdings (SPNE) United States $0.218B 0.00
TransEnterix (TRXC) United States $0.213B 0.00
Stereotaxis (STXS) United States $0.188B 0.00
Neuronetics (STIM) United States $0.183B 0.00
ConforMIS (CFMS) United States $0.139B 0.00
Sensus Healthcare (SRTS) United States $0.108B 0.00
Second Sight Medical Products (EYES) United States $0.096B 0.00
EDAP TMS S.A (EDAP) France $0.093B 0.00
Apollo Endosurgery (APEN) United States $0.073B 0.00
Spectral Diagnostics (EDTXF) Canada $0.065B 0.00
Ekso Bionics Holdings (EKSO) United States $0.062B 0.00
Vermillion (VRML) United States $0.054B 0.00
Helius Medical Technologies (HSDT) United States $0.048B 0.00
Electromed (ELMD) United States $0.044B 22.61
T2 Biosystems (TTOO) United States $0.040B 0.00
Xtant Medical Holdings (XTNT) United States $0.038B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.028B 0.00
Restoration Robotics (HAIR) United States $0.027B 0.00
Ra Medical Systems (RMED) United States $0.027B 0.00
Nuvectra (NVTR) United States $0.026B 0.00
Bioanalytical Systems (BASI) United States $0.026B 0.00
ReWalk Robotics (RWLK) Israel $0.023B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
American Shared Hospital Services (AMS) United States $0.015B 21.58
Lianluo Smart (LLIT) China $0.014B 0.00
OBALON THERPTCS (OBLN) United States $0.013B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Dynatronics (DYNT) United States $0.011B 0.00
Avinger (AVGR) United States $0.011B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
Micron Solutions (MICR) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.005B 0.00
Viveve Medical (VIVE) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00